These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8028190)

  • 1. [Progress in the red cell substitutes (artificial red cells)].
    Tsuchida E
    Rinsho Ketsueki; 1994 May; 35(5):439-45. PubMed ID: 8028190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress and trend in the development of artificial blood].
    Tsuchida E
    Nihon Rinsho; 1994 Sep; 52(9):2483-91. PubMed ID: 7967100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
    Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
    Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
    Sakai H; Tsuchida E
    Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical properties of hemoglobin vesicles as red cell substitutes.
    Sakai H; Hamada K; Takeoka S; Nishide H; Tsuchida E
    Biotechnol Prog; 1996; 12(1):119-25. PubMed ID: 8845102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier.
    Taguchi K; Urata Y; Anraku M; Maruyama T; Watanabe H; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Kai T; Otagiri M
    Drug Metab Dispos; 2009 Jul; 37(7):1456-63. PubMed ID: 19364827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Artificial blood].
    Kobayashi K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):31-7. PubMed ID: 15696696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified hemoglobin solution as a resuscitation fluid.
    DeVenuto F
    Vox Sang; 1983 Mar; 44(3):129-42. PubMed ID: 6340353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of size distribution and encapsulation efficiency of liposome-encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle static light scattering.
    Arifin DR; Palmer AF
    Biotechnol Prog; 2003; 19(6):1798-811. PubMed ID: 14656159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of artificial oxygen carrier (synthetic erythrocytes) and the ability to supply oxygen to tissues].
    Tsuchida E; Sou K; Sakai H; Komatsu K; Takeoka S; Horinouchi H; Suematsu M; Kobayashi K
    Masui; 2003 Dec; 52 Suppl():S55-66. PubMed ID: 14870565
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonencapsulated hemoglobin-based red blood cell substitutes: an updated view.
    Sheffield CL; DeLoach JR
    Biotechnol Appl Biochem; 1991 Dec; 14(3):249-55. PubMed ID: 1777112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and challenge of modified hemoglobins as red blood cell substitutes].
    Lu XL
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Static structures and dynamics of hemoglobin vesicle (HBV) developed as a transfusion alternative.
    Sato T; Sakai H; Sou K; Medebach M; Glatter O; Tsuchida E
    J Phys Chem B; 2009 Jun; 113(24):8418-28. PubMed ID: 19469497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylation promotes hemoglobin tetramer dissociation.
    Caccia D; Ronda L; Frassi R; Perrella M; Del Favero E; Bruno S; Pioselli B; Abbruzzetti S; Viappiani C; Mozzarelli A
    Bioconjug Chem; 2009 Jul; 20(7):1356-66. PubMed ID: 19534518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
    Kim HW; Greenburg AG
    Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine tuning of polymerized pyridoxylated hemoglobin as a red blood cell substitute.
    Hsia CJ
    Prog Clin Biol Res; 1989; 319():339-49. PubMed ID: 2622918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen carriers.
    Chang TM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1187-90. PubMed ID: 12211412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell substitutes.
    Chang TM
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):651-67. PubMed ID: 11102282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.